Supporting Information
Protocol S1
Sampling method for checking antibody specificity Reagents -Secretase inhibitor IV, 12-O-tetradecanoylphorbol 13-acetate (TPA), and TNF- protease inhibitor-2 (TAPI-2) were purchased from Merck (Darmstadt, Germany), Wako Pure Chemicals (Osaka, Japan), and Peptide Institute (Osaka, Japan), respectively. All reagents were dissolved in sterilized dimethyl sulfoxide (DMSO) and added to the cell culture medium to yield 0.1% DMSO as final concentration.
Cell culture
H4 neuroglioma cells stably expressing wild-type human APP 695 (APP WT -H4 cells) [1] (expression vector pCEP4; Invitrogen, San Diego, CA) were cultured in Dulbecco's modified Eagle's medium (Invitrogen, San Diego, CA) at 37°C with 5% CO 2 .
The medium was supplemented with 10% fetal bovine serum (Invitrogen), 100 U/mL penicillin, 100 μg/mL streptomycin (Invitrogen), and 150 μg/mL hygromycin B (Wako).
APP WT -H4 cells were plated at a density of 1.5 × 10 5 cells per 60-mm dish. After 48-h incubation, the conditioned media were replaced by new media containing the indicated reagent. Twenty-four hours after replacement of the media, the cultured media were harvested and precipitated with heparin agarose resin (Thermo Fisher Scientific, Rockford, IL), as described previously [2] .
